Ionis Prescribed drugs (IONS) Reviews Q3 Decline, Lags Earnings Estimates
Ionis Prescription drugs (IONS) arrived out with a quarterly decline of $.22 for every share vs . the Zacks Consensus...
Ionis Prescription drugs (IONS) arrived out with a quarterly decline of $.22 for every share vs . the Zacks Consensus...
Jazz Pharmaceuticals (JAZZ) - Get Report beat Wall Street's 3rd-quarter earnings expectations as the biopharma posted an enhance in oncology-item income. ...
SOUTH SAN FRANCISCO, Calif., Nov. 2, 2020 /PRNewswire/ -- Titan Prescribed drugs, Inc. (NASDAQ:TTNP) today announced the completion of its arrangement...
Vallon Pharmaceuticals (VALL) intends to elevate $17.25 million in an IPO of its common inventory, in accordance to an S-1...